Details Basic Details Date Thursday, September 17, 2020 Type Presentation Materials Replication of Protocol-Based Analyses of Saxagliptin and Sitagliptin using Sentinel Modular Programs Additional Information Information Host 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Acute Myocardial Infarction and Heart Failure following Saxagliptin or Sitagliptin Use: A Propensity Score Matched Analysis ICPE All Access Conference Abstracts Sentinel Drug Study: Onglyza (Saxagliptin) and Januvia (Sitagliptin) & Acute Myocardial Infarction (AMI) and Hospitalized Heart Failure Contributors Presenter(s) Christian Hampp, Sheryl Kluberg, Laura Hou, Sengwee Toh, David Graham, Rongmei Zhang, Yandong Qiang, Justin Bohn